載入...
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
INTRODUCTION: Following growing evidence to support the safety, local control (LC) and potential improvement in overall survival (OS) in patients with oligometastatic non-small cell lung cancer (NSCLC) that have been treated with local ablative therapy such as stereotactic ablative radiotherapy (SAB...
Na minha lista:
| 發表在: | BMJ Open |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5905762/ https://ncbi.nlm.nih.gov/pubmed/29666135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-020690 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|